Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.20.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common stock
Additional paid-in capital
Accumulated deficit
Total
Balances at Dec. 31, 2018 $ 5,838 $ 1,244,273 $ (1,481,973) $ (231,862)
Balances (in Shares) at Dec. 31, 2018 5,838,149      
Surrender of common shares in settlement of due from stockholder balance $ (575) (1,608,258) (1,608,833)
Surrender of common shares in settlement of due from stockholder balance (in Shares) (574,991)      
Conversion of Series A Convertible Preferred Stock into common stock $ 619 5,980,326 5,980,945
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) 619,138      
Issuance of common stock $ 1,283 5,883,078 5,884,361
Issuance of common stock (in Shares) 1,283,124      
Series A Convertible Preferred share issuance $ 10 99,990 100,000
Series A Convertible Preferred share issuance (in Shares) 10,000      
Conversion of notes payable - related party into Series A Convertible Preferred share issuance $ 190 1,899,810 1,900,000
Conversion of notes payable - related party into Series A Convertible Preferred share issuance (in Shares) 190,000      
Shares issued in cashless exercise of warrants $ 4 (4)
Shares issued in cashless exercise of warrants (in Shares) 3,732      
Warrants exercised for cash $ 11 67,537 67,548
Warrants exercised for cash (in Shares) 11,075      
Settlement of disputed contractual claim $ 20 117,982 118,002
Settlement of disputed contractual claim (in Shares) 19,801      
Issuance of warrants in settlement of lease dispute $ 66,275 $ 66,275
Stock-based compensation related to founder’s transfers of common shares to contractors (in Shares) 5,322,930 5,322,930
Stock-based compensation related to employee and contractor equity awards $ 3 $ 527,440 $ 527,443
Stock-based compensation related to employee and contractor equity awards (in Shares) 3,290      
Stock and warrant dividend (1,705,722) (1,705,722)
Net Loss (8,210,920) (8,210,920)
Ending balance at Jun. 30, 2019 $ 819 $ 6,584 17,895,657 (9,692,893) 8,210,167
Ending balance (in Shares) at Jun. 30, 2019 819,138 6,584,180      
Balances at Mar. 31, 2019 $ 816 $ 6,563 17,525,614 (7,196,682) 10,336,311
Balances (in Shares) at Mar. 31, 2019 816,638 6,563,195      
Conversion of Series A Convertible Preferred Stock into common stock $ 3 24,997 25,000
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) 2,500      
Warrants exercised for cash $ 1 6,524 6,525
Warrants exercised for cash (in Shares) 1,184      
Settlement of disputed contractual claim $ 20 $ 117,982 $ 118,002
Settlement of disputed contractual claim (in Shares) 19,801      
Stock-based compensation related to founder’s transfers of common shares to contractors (in Shares) 220,540 220,540
Net Loss $ (2,496,211) $ (2,496,211)
Ending balance at Jun. 30, 2019 $ 819 $ 6,584 17,895,657 (9,692,893) 8,210,167
Ending balance (in Shares) at Jun. 30, 2019 819,138 6,584,180      
Balances at Dec. 31, 2019 $ 579 $ 7,391 19,712,115 (12,794,473) 6,925,612
Balances (in Shares) at Dec. 31, 2019 578,567 7,390,261      
Conversion of Series A Convertible Preferred Stock into common stock $ (484) $ 1,273 (789)
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) (483,695) 1,272,884      
Settlement of Accounts Payable   $ 285 1,757,905 1,758,190
Settlement of Accounts Payable (in Shares)   284,567      
Shares issued in cashless exercise of warrants $ 347 (347)
Shares issued in cashless exercise of warrants (in Shares) 347,189      
Shares issued in cashless exercise of options $ 57 (57)
Shares issued in cashless exercise of options (in Shares) 57,534      
Warrants exercised for cash $ 7 38,563 38,570
Warrants exercised for cash (in Shares) 7,000      
Shares issued to current and former employees and directors $ 131 2,356,416 2,356,547
Shares issued to current and former employees and directors (in Shares) 131,147      
Net Loss (4,899,453) (4,899,453)
Ending balance at Jun. 30, 2020 $ 95 $ 9,491 23,863,806 (17,693,926) 6,179,466
Ending balance (in Shares) at Jun. 30, 2020 94,872 9,490,582      
Balances at Mar. 31, 2020 $ 511 $ 7,636 20,079,538 (13,944,124) 6,143,561
Balances (in Shares) at Mar. 31, 2020 511,067 7,634,561      
Conversion of Series A Convertible Preferred Stock into common stock $ (416) $ 1,095 (679)
Conversion of Series A Convertible Preferred Stock into common stock (in Shares) (416,195) 1,095,251      
Settlement of Accounts Payable $ 285 1,757,905 1,758,190
Settlement of Accounts Payable (in Shares) 284,567      
Shares issued in cashless exercise of warrants $ 347 (347)
Shares issued in cashless exercise of warrants (in Shares) 347,189      
Shares issued in cashless exercise of options $ 57 (57)
Shares issued in cashless exercise of options (in Shares) 57,534      
Warrants exercised for cash $ 7 38,563 38,570
Warrants exercised for cash (in Shares) 7,000      
Shares issued to current and former employees and directors $ 64 1,988,883 1,988,947
Shares issued to current and former employees and directors (in Shares) 64,480      
Net Loss (3,749,802) (3,749,802)
Ending balance at Jun. 30, 2020 $ 95 $ 9,491 $ 23,863,806 $ (17,693,926) $ 6,179,466
Ending balance (in Shares) at Jun. 30, 2020 94,872 9,490,582